These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 17323845)

  • 1. Icodextrin:a major problem for glucose dehydrogenase-based glucose point of care testing systems.
    Floré K; Delanghe J
    Acta Clin Belg; 2006; 61(6):351-4. PubMed ID: 17323845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A previously undescribed side effect of icodextrin: overestimation of glycemia by glucose analyzer.
    Wens R; Taminne M; Devriendt J; Collart F; Broeders N; Mestrez F; Germanos H; Dratwa M
    Perit Dial Int; 1998; 18(6):603-9. PubMed ID: 9932659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [False measurement of glucose during dialysis with icodextrin].
    Husøy AM; Knudsen GR; Thierley M; Svarstad E
    Tidsskr Nor Laegeforen; 2006 Sep; 126(17):2268-70. PubMed ID: 16967067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Falsely Elevated Glucose Concentrations in Peritoneal Dialysis Patients Using Icodextrin.
    Dogan K; Kayalp D; Ceylan G; Azak A; Senes M; Duranay M; Yucel D
    J Clin Lab Anal; 2016 Sep; 30(5):506-9. PubMed ID: 26511081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A quantitative appraisal of interference by icodextrin metabolites in point-of-care glucose analyses.
    Apperloo JJ; Vader HL
    Clin Chem Lab Med; 2005; 43(3):314-8. PubMed ID: 15843238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The danger of using inappropriate point-of-care glucose meters in patients on icodextrin dialysis.
    Perera NJ; Stewart PM; Williams PF; Chua EL; Yue DK; Twigg SM
    Diabet Med; 2011 Oct; 28(10):1272-6. PubMed ID: 21679233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of a dialysis solution with icodextrin on ultrafiltration and selected metabolic parameters in patients treated with peritoneal dialysis].
    Opatrná S; Racek J; Stehlík P; Senft V; Sefrna F; Topolcan O; Opatrný K
    Cas Lek Cesk; 2002 May; 141(9):281-5. PubMed ID: 12061197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytical interferences in point-of-care testing glucometers by icodextrin and its metabolites: an overview.
    Floré KM; Delanghe JR
    Perit Dial Int; 2009; 29(4):377-83. PubMed ID: 19602602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood glucose overestimation in diabetic patients on continuous ambulatory peritoneal dialysis for end-stage renal disease.
    Oyibo SO; Pritchard GM; McLay L; James E; Laing I; Gokal R; Boulton AJ
    Diabet Med; 2002 Aug; 19(8):693-6. PubMed ID: 12147153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inaccurate self-monitoring of blood glucose readings in patients on chronic ambulatory peritoneal dialysis with icodextrin.
    Pavlicek V; Garzoni D; Urech P; Brändle M
    Exp Clin Endocrinol Diabetes; 2006 Mar; 114(3):124-6. PubMed ID: 16636978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe peritoneal mononucleosis associated with icodextrin use in continuous ambulatory peritoneal dialysis.
    Martín J; Sansone G; Cirugeda A; Sánchez-Tomero JA; Muñoz C; Selgas R
    Adv Perit Dial; 2003; 19():191-4. PubMed ID: 14763060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hypoglycaemic coma due to falsely elevated glucose values in a patient with diabetes mellitus and peritoneal dialysis].
    Nienhuis WA; Bruijns RH; Vastenburg G; Wouters RS
    Ned Tijdschr Geneeskd; 2006 Jul; 150(28):1574-6. PubMed ID: 16886696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe cutaneous hypersensitivity to icodextrin in a continuous ambulatory peritoneal dialysis patient.
    Lee SH; Park HC; Sim SR; Chung SJ; Kim KJ; Park WI; Hong SW; Ha SK
    J Nephrol; 2006; 19(5):673-6. PubMed ID: 17136700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of icodextrin to provide adequate ultrafiltration in continuous ambulatory peritoneal dialysis patients.
    Thodis E; Passadakis P; Panagoutsos S; Marinopoulos D; Vargemezis V
    Adv Perit Dial; 1999; 15():171-4. PubMed ID: 10682096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful use of icodextrin in elderly patients on continuous ambulatory peritoneal dialysis.
    Nakamoto H; Babazono T; Kasai K; Kuriyama S; Sugimoto T; Nakayama M; Hamada C; Furuya R; Hasegawa H; Kasahara M; Moriishi M; Tomo T; Miyazaki M; Yorioka N; Sato M; Yamabe K; Kawaguchi Y
    Adv Perit Dial; 2005; 21():168-74. PubMed ID: 16686312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between peritoneal permeability and ultrafiltration volume with icodextrin-based peritoneal dialysis solution.
    Moriishi M; Kawanishi H; Watanabe H; Tsuchiya S
    Adv Perit Dial; 2004; 20():166-9. PubMed ID: 15384820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Icodextrine and insulin resistance in continuous ambulatory peritoneal dialysis patients.
    Canbakan M; Sahin GM
    Ren Fail; 2007; 29(3):289-93. PubMed ID: 17497442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Icodextrin - still a cause for concern with blood glucose monitoring in continuous ambulatory peritoneal dialysis patients with diabetes.
    Slim S; Griffiths MJ; Gama R
    Ann Clin Biochem; 2007 Mar; 44(Pt 2):196-7. PubMed ID: 17362588
    [No Abstract]   [Full Text] [Related]  

  • 19. Glycemic control in diabetic CAPD patients assessed by continuous glucose monitoring system (CGMS).
    Marshall J; Jennings P; Scott A; Fluck RJ; McIntyre CW
    Kidney Int; 2003 Oct; 64(4):1480-6. PubMed ID: 12969169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertonic glucose-based peritoneal dialysate is associated with higher blood pressure and adverse haemodynamics as compared with icodextrin.
    Selby NM; Fonseca S; Hulme L; Fluck RJ; Taal MW; McIntyre CW
    Nephrol Dial Transplant; 2005 Sep; 20(9):1848-53. PubMed ID: 15972319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.